FindTrial
Sign In

A multi-biomarker model established and validated for predicting lupus nephritis in patients with systemic lupus erythematosus: a study protocol

A multi-biomarker model established and validated for predicting lupus nephritis in patients with systemic lupus erythematosus: a study protocol

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230526004
Enrollment
200
Registered
2023-05-26
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus nephritis in patients with systemic lupus erythematosus Lupus nephritis, systemic lupus erythematosus, predict model

Interventions

Lupus nephritis in patients with systemic lupus erythematosus,No patients with systemic lupus erythematosus developed lupus nephritis
Diagnostic,Diagnostic
LN group,non-LN group

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: expectant SLE patients who met the diagnostic criteria, were between the age of 18 and 45, and consented to be part of the study and completed a consent form

Exclusion criteria

Exclusion criteria: Patients with other renal-related problems, such as glomerulonephritis

Design outcomes

Primary

MeasureTime frame
LN Biological indicators before and after the onset of lupus nephritis LN diagnose—

Secondary

MeasureTime frame
Biomarker level changes Before LN and after Blood and Urine test—

Countries

China

Contacts

Public ContactLiping Hu

Department of Clinical Laboratory, Zigong Third People's Hospital, Zigong City, China.

a18623520085@gmail.com15390375505

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026